Purchases and Sales Made in Q3 2024 in Lineage Cell Therapeutics, Inc. (LCTX)
This table provides information about the institutional ownership of Lineage Cell Therapeutics, Inc. (LCTX) during Q3 2024. The information is specifically focused on institutions that hold shares of Lineage Cell Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Oct 24, 2024
Q3 2024
|
Riggs Asset Managment Co. Inc.
|
SELL
|
- |
-8.6K- 89.58% |
$6.88K - $9.63K
|
1K
$950
|
|
|
Nov 08, 2024
Q3 2024
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-16.3K- 7.86% |
$13.1K - $18.3K
|
191K
$182K
|
|
|
Nov 14, 2024
Q3 2024
|
High Tower Advisors, LLC
Chicago, IL |
SELL
|
- |
-17.1K- 30.65% |
$13.7K - $19.1K
|
38.6K
$36.7K
|
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-18.8K- 60.26% |
$15K - $21K
|
12.4K
$11.8K
|
|
|
Nov 14, 2024
Q3 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-57.2K- 34.58% |
$45.8K - $64.1K
|
108K
$103K
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-60.3K- 84.58% |
$48.3K - $67.6K
|
11K
$10.4K
|
|
|
Jun 26, 2025
Q3 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-116K- 66.21% |
$92.5K - $130K
|
59K
$56.1K
|
|
|
Nov 14, 2024
Q3 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-121K- 82.5% |
$96.5K - $135K
|
25.6K
$24.3K
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-123K- 50.65% |
$98.4K - $138K
|
120K
$114K
|
|
|
Nov 14, 2024
Q3 2024
|
Prescott General Partners LLC
Boca Raton, FL |
SELL
|
- |
-234K- 37.74% |
$187K - $262K
|
386K
$367K
|
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-387K- 66.23% |
$309K - $433K
|
197K
$187K
|
|
|
Nov 14, 2024
Q3 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-626K- 96.65% |
$501K - $701K
|
21.7K
$20.6K
|